(17:03 GMT) Viridian Therapeutics Price Target Raised to $31.00/Share From $20.00 by Wells Fargo
Dow Jones Newswires
Viridian Therapeutics Raised to Overweight From Equal-Weight by Wells Fargo
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:VRDN
- Language
- English